ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

HARP Harpoon Therapeutics Inc

23.01
0.00 (0.00%)
2024年5月3日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Harpoon Therapeutics Inc HARP NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.00 0.00% 23.01 09:00:00
始値 安値 高値 終値 前日終値
23.01 23.01
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/3/1206:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/1122:55EDGAR2Form POS AM - Post-Effective amendments for registration..
2024/3/1122:46EDGAR2Form S-8 POS - Securities to be offered to employees in..
2024/3/1121:47EDGAR2Form 8-K - Current report
2024/3/0906:04EDGAR2Form 8-K - Current report
2024/2/2821:37EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
2024/2/2821:34EDGAR2Form 8-K - Current report
2024/2/2222:32EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
2024/2/2222:31EDGAR2Form 8-K - Current report
2024/2/0821:00EDGAR2Form DEFM14A - Definitive proxy statement relating to merger..
2024/2/0706:15EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/1/3006:52EDGAR2Form PREM14A - Preliminary proxy statements relating to..
2024/1/3006:28EDGAR2Form 8-K - Current report
2024/1/1105:07PRNUSKuehn Law Encourages AMAM, HARP, AXNX, and CPE Investors to..
2024/1/0920:12IHMARKETNEWSWall Street Highlights: HPE and Juniper Networks in..
2024/1/0907:20EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
2024/1/0907:16EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
2024/1/0822:04EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
2024/1/0822:01EDGAR2Form 8-K - Current report
2024/1/0821:30BWMerck to Acquire Harpoon Therapeutics, Further Diversifying..
2024/1/0607:04EDGAR2Form S-8 - Securities to be offered to employees in employee..
2023/12/2621:30GLOBEHarpoon Therapeutics Strengthens Leadership Team
2023/12/2306:06EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2023/12/2014:15EDGAR2Form EFFECT - Notice of Effectiveness
2023/12/1921:30GLOBEHarpoon Therapeutics Abstract for HPN328 Accepted for Rapid..
2023/12/1210:15GLOBEHarpoon Therapeutics Presents HPN217 Phase 1 Clinical Data..
2023/12/0906:08EDGAR2Form S-3 - Registration statement under Securities Act of..
2023/11/2906:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/2906:14EDGAR2Form 8-K - Current report
2023/11/2504:06EDGAR2Form 8-K - Current report
2023/11/2504:01EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/11/1006:28EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/1006:11EDGAR2Form 8-K - Current report
2023/11/1006:01GLOBEHarpoon Therapeutics Reports Third Quarter 2023 Financial..
2023/11/0405:05EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2023/11/0222:15GLOBEHarpoon Therapeutics Abstract for HPN217 Accepted for..
2023/10/2706:00EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2023/10/2321:00EDGAR2Form 8-K - Current report
2023/10/2320:17GLOBEHarpoon Therapeutics Announces Up to $150 Million Private..
2023/10/2200:31GLOBEHarpoon Therapeutics Announces Updated Interim Tolerability..
2023/10/1705:05GLOBEHarpoon Therapeutics to Host Webcast Reviewing HPN328..
2023/10/1005:17GLOBEHarpoon Therapeutics to Present Interim Tolerability and..
2023/10/0306:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/2816:00GLOBEHarpoon Therapeutics Presents HPN217 Interim Phase 1 Data at..
2023/9/1520:15GLOBEHarpoon Therapeutics Announces First Patients with Small..
2023/9/1406:12DJNHarpoon Shares Drop 7.3% as AbbVie Declines License Option
2023/9/1405:55DJNHarpoon Therapeutics Says AbbVie Declines to Exercise..
2023/9/1405:15EDGAR2Form 8-K - Current report
2023/9/1405:05GLOBEHarpoon Therapeutics Provides an Update on the HPN217..
2023/9/0620:30GLOBEHarpoon Therapeutics Abstract for HPN217 Accepted for Poster..

最近閲覧した銘柄

Delayed Upgrade Clock